TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35320692

Group type: EXPERIMENTAL
Intervention: Ten20 Conductive PasteTM with Tensive® adhesive gel and hydrogel electrodes on hairless locations (Group 2)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Ten20 Conductive PasteTM with Tensive® adhesive gel (Group 1)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 79
Study: 32549168

Group type: EXPERIMENTAL
Intervention: Bhramari pranayama (Bhr.P)
Number of subjects: 520

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 520
Study: 35576721

Group type: EXPERIMENTAL
Intervention: Mammographic tumour features (imaging biomarkers)
Number of subjects: 0
Study: 34403795

Group type: EXPERIMENTAL
Intervention: Implementation of the American College of Surgeons National Surgical Quality Improvement Program (NSQIP)
Number of subjects: 0
Study: 33469276

Group type: EXPERIMENTAL
Intervention: High impact weight-bearing/high-intensity/velocity resistance training (EG: n=27) exercising three times a week
Number of subjects: 54

Group type: COMPARATOR
Intervention: Attendance control group (CG: n=27) performing low-intensity exercise once a week
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: High impact weight-bearing/high-intensity/velocity resistance training (EG: n=27)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Attendance control group (CG: n=27)
Number of subjects: 54
Study: 32246302

Group type: EXPERIMENTAL
Intervention: DM removal before trephination (group 1; 43 eyes)
Number of subjects: 83

Group type: COMPARATOR
Intervention: DM removal after trephination (group 2; 40 eyes)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Comparison of roundness and precision of donor button cuts
Number of subjects: 83
Study: 35234569

Group type: EXPERIMENTAL
Intervention: Intervention group (doubled dosing interval and discontinued etanercept after 6 months)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (continued standard dose for 6 months and then doubled dosing interval)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 160
Study: 33526504

Group type: EXPERIMENTAL
Intervention: Reminiscence therapy using virtual reality (VR)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Active control using a laptop computer or physical items
Number of subjects: 45

Group type: COMPARATOR
Intervention: Passive control
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: VR group
Number of subjects: 45
Study: 33559381

Group type: EXPERIMENTAL
Intervention: High schizotypy group
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Self-report measures
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Lexical measures
Number of subjects: 80
Study: 35048253

Group type: EXPERIMENTAL
Intervention: Massage Therapy (MT)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Neuromuscular Electrical Stimulation (NMES)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 160
Study: 32056126

Group type: EXPERIMENTAL
Intervention: Deep learning model (faster RCNN) for automatic detection of aneurysms
Number of subjects: 311
Study: 34980119

Group type: EXPERIMENTAL
Intervention: HEPA air cleaners
Number of subjects: 75
Study: 32490948

Group type: EXPERIMENTAL
Intervention: Occupational stress assessment using the demand‐control model proposed by Karasek.
Number of subjects: 126
Study: 36136603

Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RE)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Concurrent Exercise (CE)
Number of subjects: 9
Study: 35630050

Group type: EXPERIMENTAL
Intervention: 980 nm Gallium−Aluminum−Arsenide diode laser (0.8 W output power, energy density of 5.33 J/mm2, for 30 s)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser (0.75 W power, 75 mJ pulse energy, pulse repetition rate of 10 Hz, 5 J/mm2 fluency, average exposure time of 30 s)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Negative control (no treatment)
Number of subjects: 30
Study: 34338883

Group type: EXPERIMENTAL
Intervention: Higher protein diet (HP; 24.3 energy% protein)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Normal protein diet (NP; 18.6 energy% protein)
Number of subjects: 34
Study: 32933575

Group type: EXPERIMENTAL
Intervention: WeChat group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Leaflet group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 35291006

Group type: EXPERIMENTAL
Intervention: Snare-assisted POEM
Number of subjects: 75

Group type: COMPARATOR
Intervention: Conventional endoscopic knife (HookKnife)
Number of subjects: 75
Study: 32382137

Group type: EXPERIMENTAL
Intervention: Escitalopram/memantine combination treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Escitalopram
Number of subjects: 0
Study: 33040817

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine combined with ropivacaine (Group B)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Ropivacaine alone (Group A)
Number of subjects: 90
Study: 34311755

Group type: EXPERIMENTAL
Intervention: Huoxiang Zhengqi (HXZQ) oral liquid
Number of subjects: 212

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 212
Study: 32186926

Group type: EXPERIMENTAL
Intervention: Tidal Model-Based Psychiatric Nursing Approach (7 one to one sessions)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 27
Study: 34130243

Group type: EXPERIMENTAL
Intervention: D-cycloserine (100 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 32971005

Group type: EXPERIMENTAL
Intervention: Durvalumab monotherapy (1500 mg IV every 4 weeks)
Number of subjects: 1032

Group type: EXPERIMENTAL
Intervention: Durvalumab plus tremelimumab (1500 mg durvalumab + 75 mg tremelimumab IV every 4 weeks for up to four doses, followed by durvalumab maintenance)
Number of subjects: 1032

Group type: COMPARATOR
Intervention: Chemotherapy (gemcitabine plus cisplatin or gemcitabine plus carboplatin for up to six cycles)
Number of subjects: 1032

Group type: EXPERIMENTAL
Intervention: Durvalumab
Number of subjects: 1032

Group type: EXPERIMENTAL
Intervention: Durvalumab plus tremelimumab
Number of subjects: 1032

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 1032
Study: 616026366

Group type: EXPERIMENTAL
Intervention: Brimonidine 0.2% - Timolol 0.5% (Combigan)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Baseline elevated IOP
Number of subjects: 62
Study: 33031829

Group type: EXPERIMENTAL
Intervention: FF/UMEC/VI 100/62.5/25 μg
Number of subjects: 10355

Group type: COMPARATOR
Intervention: FF/VI 100/25 μg
Number of subjects: 10355

Group type: COMPARATOR
Intervention: UMEC/VI 62.5/25 μg
Number of subjects: 10355
Study: 35909376

Group type: EXPERIMENTAL
Intervention: Braided absorbable polyglactin suture
Number of subjects: 40

Group type: COMPARATOR
Intervention: Braided nonabsorbable polyethylene terephthalate suture
Number of subjects: 40
Study: 33950929

Group type: EXPERIMENTAL
Intervention: Silver needle treatment group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine western medicine treatment group
Number of subjects: 0
Study: 34222105

Group type: COMPARATOR
Intervention: Titanium prosthesis
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Polycel prosthesis
Number of subjects: 106
Study: 33287815

Group type: EXPERIMENTAL
Intervention: Home telemonitoring intervention
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Focus groups and structured interviews
Number of subjects: 12
Study: 35216619

Group type: EXPERIMENTAL
Intervention: Lumen-apposing metal stent (LAMS) plus double-pigtail plastic stent (DPS)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Lumen-apposing metal stent (LAMS)
Number of subjects: 84
Study: 32299853

Group type: EXPERIMENTAL
Intervention: Loaded breathing using an inspiratory threshold load
Number of subjects: 40

Group type: COMPARATOR
Intervention: Unloaded breathing
Number of subjects: 40
Study: 32949087

Group type: EXPERIMENTAL
Intervention: Cisplatin (cis-RT)
Number of subjects: 546

Group type: COMPARATOR
Intervention: Cetuximab (cetux-RT)
Number of subjects: 546
Study: 33082181

Group type: EXPERIMENTAL
Intervention: Tablet-delivered educational videos on physical activity, blood pressure, diet, medications, smoking, and general health (n=220)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Extra video on CPR (substudy, randomised 1:1)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Usual care (n=110)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Tablet-delivered educational videos (n=220)
Number of subjects: 330
Study: 36294349

Group type: EXPERIMENTAL
Intervention: Denneroll™ thoracic traction orthosis (DTTO)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (multimodal program without DTTO)
Number of subjects: 80
Study: 33944578

Group type: EXPERIMENTAL
Intervention: XTJ2 conidial suspension (1×10^5 spores/mL)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 15
Study: 36368479

Group type: EXPERIMENTAL
Intervention: Intravenous ferric derisomaltose (1000 mg single dose)
Number of subjects: 746

Group type: COMPARATOR
Intervention: Oral ferrous sulfate (325 mg tablet, 1–3 times daily)
Number of subjects: 746
Study: 33384827

Group type: EXPERIMENTAL
Intervention: Semi-fixed oral appliance (OA)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Fixed oral appliance (OA)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Baseline (without OA)
Number of subjects: 15
Study: 35893907

Group type: EXPERIMENTAL
Intervention: Vitamin D (25,000 IU per day over 4 consecutive days, followed by 25,000 IU per week up to 6 weeks)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Vitamin D
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 33820784

Group type: EXPERIMENTAL
Intervention: AMBIsome Therapy Induction Optimisation (AMBITION) Trial
Number of subjects: 0
Study: 33234528

Group type: EXPERIMENTAL
Intervention: Integrated WASH and nutrition intervention
Number of subjects: 0
Study: 35582957

Group type: EXPERIMENTAL
Intervention: Renal denervation (RDN)
Number of subjects: 222
Study: 32778876

Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg daily)
Number of subjects: 19114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19114
Study: 34038529

Group type: EXPERIMENTAL
Intervention: Nutrition-intensified antenatal care (I-ANC)
Number of subjects: 660

Group type: COMPARATOR
Intervention: Standard antenatal care (S-ANC)
Number of subjects: 660
Study: 32972066

Group type: EXPERIMENTAL
Intervention: Polyvinyl alcohol group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Polyurethane group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 60
Study: 35767198

Group type: EXPERIMENTAL
Intervention: S-1 dosage formula recommended dose based on renal function
Number of subjects: 686

Group type: COMPARATOR
Intervention: Control group (ED and UD)
Number of subjects: 686
Study: 33027217

Group type: EXPERIMENTAL
Intervention: Respiratory Muscle Training (RMT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard Rehabilitation (SR)
Number of subjects: 44
Study: 33152781

Group type: EXPERIMENTAL
Intervention: Invitation to a web‐based self‐test for rehabilitation needs (n=4000)
Number of subjects: 8000

Group type: COMPARATOR
Intervention: Control group (n=4000)
Number of subjects: 8000
Study: 32663760

Group type: EXPERIMENTAL
Intervention: Liposomal doxorubicin (Caelyx®)
Number of subjects: 0
Study: 33749084

Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus salivarius subs. salicinius AP‐32, Lactobacillus paracasei ET‐66, Lactobacillus plantarum LPL28)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 33274370

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG) 1 × 10^10 CFU twice daily for 5 days
Number of subjects: 813

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 813
Study: 34272183

Group type: EXPERIMENTAL
Intervention: Proton therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intensity-modulated radiotherapy (IMRT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stereotactic body radiotherapy (SBRT)
Number of subjects: 0
Study: 35025543

Group type: EXPERIMENTAL
Intervention: 12-session cognitive-behavioral therapy (CBT)
Number of subjects: 952

Group type: EXPERIMENTAL
Intervention: 12-session twelve-step facilitation (TSF)
Number of subjects: 952

Group type: EXPERIMENTAL
Intervention: 4-session motivational enhancement therapy (MET)
Number of subjects: 952

Group type: EXPERIMENTAL
Intervention: Attendance in TSF and MET
Number of subjects: 952

Group type: EXPERIMENTAL
Intervention: Attendance in CBT
Number of subjects: 952
Study: 33132156

Group type: EXPERIMENTAL
Intervention: High-speed circuit resistance training (HSCT) for 8 weeks, three times per week.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (CON) did not perform formal training.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High-speed circuit resistance training (HSCT) group.
Number of subjects: 20
Study: 36233462

Group type: EXPERIMENTAL
Intervention: Hypopressive exercise program (moderate intensity, 12 weeks duration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34347634

Group type: EXPERIMENTAL
Intervention: Benson Relaxation Technique
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine Care
Number of subjects: 70
Study: 35951067

Group type: EXPERIMENTAL
Intervention: Qigong intervention (the 'white ball' system) taught by a traditional Chinese medicine specialist for 4 weeks followed by 4 weeks of self-practice
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 44
Study: 34039341

Group type: EXPERIMENTAL
Intervention: Self-collected HPV test (SC-HPV) followed by pap smear (PS) in case of positivity
Number of subjects: 687

Group type: COMPARATOR
Intervention: Pap smear (PS)
Number of subjects: 687
Study: 32738222

Group type: EXPERIMENTAL
Intervention: 13-point risk score incorporating four pre-transplant variables (age, dialysis dependence, serum bilirubin level, mechanical ventilation)
Number of subjects: 1388

Group type: EXPERIMENTAL
Intervention: Risk scores of four points or higher
Number of subjects: 1388

Group type: EXPERIMENTAL
Intervention: Logistic regression analysis
Number of subjects: 1388

Group type: EXPERIMENTAL
Intervention: Weighted regression analysis
Number of subjects: 1388

Group type: EXPERIMENTAL
Intervention: Brier score of the composite score in the validation cohort
Number of subjects: 1388
Study: 34871101

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (docetaxel, cisplatin, and fluorouracil) followed by surgery
Number of subjects: 68

Group type: COMPARATOR
Intervention: Upfront surgery (segmental resection) followed by adjuvant treatment
Number of subjects: 68
Study: 33831980

Group type: EXPERIMENTAL
Intervention: Spiritual care training including transcendental meditation (T.M) technique for 4 weeks
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 54
Study: 35272722

Group type: EXPERIMENTAL
Intervention: 0.37 g MFE in boiled rice
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 0.75 g MFE in boiled rice
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 1.12 g MFE in boiled rice
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 1.5 g MFE in rice porridge
Number of subjects: 84

Group type: COMPARATOR
Intervention: 0 g MFE (control) in boiled rice
Number of subjects: 84
Study: 35983514

Group type: EXPERIMENTAL
Intervention: Iodine supplement with IS (iodized salt)
Number of subjects: 3805

Group type: EXPERIMENTAL
Intervention: ISFP (IS + iodine-rich food + iodine preparations)
Number of subjects: 3805

Group type: EXPERIMENTAL
Intervention: Dietary iodine intake from food, IS, and drinking water
Number of subjects: 3805

Group type: EXPERIMENTAL
Intervention: Thyroid nodule prevalence
Number of subjects: 3805

Group type: EXPERIMENTAL
Intervention: TPOAb positive prevalence
Number of subjects: 3805
Study: 33612587

Group type: EXPERIMENTAL
Intervention: Cookies with WF:CP:CLF ratio of 49:49:2
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cookies with varying ratios of WF:CP:CLF (50:50:0, 49:49:2, 48:48:4, 47:47:6, 46:46:8)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cookies with varying ratios of WF:CP:CLF
Number of subjects: 15
Study: 37584046

Group type: EXPERIMENTAL
Intervention: Gross myofascial release (MFR) along with conventional physical therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional physical therapy
Number of subjects: 40
Study: 33661430

Group type: EXPERIMENTAL
Intervention: RAGT + VR (n = 30)
Number of subjects: 45

Group type: COMPARATOR
Intervention: RAGT - VR (n = 15)
Number of subjects: 45
Study: 32252250

Group type: EXPERIMENTAL
Intervention: Low-GI bar (GI = 45)
Number of subjects: 8

Group type: COMPARATOR
Intervention: High-GI bar (GI = 101)
Number of subjects: 8
Study: 32078383

Group type: EXPERIMENTAL
Intervention: Family Check-Up intervention
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Paternal depressive symptoms
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Maternal depressive symptoms
Number of subjects: 264
Study: 33942447

Group type: EXPERIMENTAL
Intervention: Shared medical appointments (SMAs)
Number of subjects: 6
Study: 32330945

Group type: EXPERIMENTAL
Intervention: HIV intervention
Number of subjects: 227

Group type: COMPARATOR
Intervention: Health promotion intervention
Number of subjects: 227
Study: 34559182

Group type: EXPERIMENTAL
Intervention: Witnessing another experiencing a reaction
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Higher affective empathy
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Higher cognitive empathy
Number of subjects: 530
Study: 32039973

Group type: EXPERIMENTAL
Intervention: Vitamin C (VitC)
Number of subjects: 11330

Group type: EXPERIMENTAL
Intervention: Thiamine (THMN)
Number of subjects: 11330

Group type: EXPERIMENTAL
Intervention: Vitamin C + Thiamine (VitC+THMN)
Number of subjects: 11330
Study: 36615910

Group type: EXPERIMENTAL
Intervention: Mixed protein groups (milk/egg/peanut/cashew/almond/shrimp/walnut/wheat/salmon/hazelnut at low, medium, or high doses)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Peanut group
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Mixture high group
Number of subjects: 180
Study: 34463311

Group type: COMPARATOR
Intervention: Intranasal corticosteroids (INCS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combination intranasal antihistamine/INCS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intranasal antihistamines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral antihistamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sublingual immunotherapy tablets (SLIT-tablets)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Montelukast
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intranasal corticosteroids (INCS) for PAR
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sublingual immunotherapy tablets (SLIT-tablets) for PAR
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral antihistamine for PAR
Number of subjects: 0
Study: 631198515

Group type: EXPERIMENTAL
Intervention: Severe WMH (Fazekas scores 5-6)
Number of subjects: 1040

Group type: EXPERIMENTAL
Intervention: Severe SDWMH
Number of subjects: 1040

Group type: EXPERIMENTAL
Intervention: Moderate WMH (Fazekas scores 3-4)
Number of subjects: 1040

Group type: EXPERIMENTAL
Intervention: PVWMH
Number of subjects: 1040
Study: 35773272

Group type: EXPERIMENTAL
Intervention: Bimodal neuromodulation combining sound and tongue stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tongue stimulation combined with only pure tones (without background wideband noise)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Only sound stimuli during the first 6 weeks, bimodal stimulation in the second 6 weeks
Number of subjects: 0
Study: 33976374

Group type: EXPERIMENTAL
Intervention: Chloroprocaine 2%
Number of subjects: 211

Group type: COMPARATOR
Intervention: Ropivacaine 0.75%
Number of subjects: 211
Study: 33002287

Group type: EXPERIMENTAL
Intervention: Sandblasting with 120 µm Al2 O3 particles
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 9% hydrofluoric acid
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser irradiation at 1 W
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser irradiation at 2 W
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser irradiation at 3 W
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser irradiation at 4 W
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser irradiation at 5 W
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser irradiation at 6 W
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 63
Study: 32043193

Group type: COMPARATOR
Intervention: Axillary dissection (AD) arm
Number of subjects: 856

Group type: EXPERIMENTAL
Intervention: MDA nomogram estimated risk
Number of subjects: 856

Group type: EXPERIMENTAL
Intervention: MSK nomogram estimated risk
Number of subjects: 856
Study: 36149682

Group type: EXPERIMENTAL
Intervention: Palliative Care (PC) intervention
Number of subjects: 57

Group type: COMPARATOR
Intervention: Usual care (control arm)
Number of subjects: 57
Study: 33763720

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD) for 8 weeks
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (habitual diet)
Number of subjects: 82
Study: 36250492

Group type: EXPERIMENTAL
Intervention: Varus alignment (VrA) ≤ 3° valgus
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Neutral alignment (NA) 3‐9° valgus
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Valgus alignment (VlA) ≥ 9° valgus
Number of subjects: 159

Group type: COMPARATOR
Intervention: All groups (VrA, NA, VlA)
Number of subjects: 159
Study: 33832307

Group type: EXPERIMENTAL
Intervention: Huayu Jianpi Fangshi decoction
Number of subjects: 60

Group type: COMPARATOR
Intervention: Huayu Fangshi placebo decoction
Number of subjects: 60
Study: 34041842

Group type: EXPERIMENTAL
Intervention: Self-help version of the New Forest Parenting Programme (NFPP-SH)
Number of subjects: 12
Study: 34844605

Group type: EXPERIMENTAL
Intervention: Targeted, theory-informed interventions
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Clinical leads
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Other educational materials and audit and feedback
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Clinical leads' perceptions
Number of subjects: 42